Related Experiment Video
Updated: May 14, 2026

Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers
Published on: February 20, 2017
Paclitaxel-conjugated PAMAM dendrimers adversely affect microtubule structure through two independent modes of action
Erika N Cline1, Ming-Hsin Li, Seok Ki Choi
1Cellular and Molecular Biology Graduate Program, University of Michigan, Ann Arbor, MI 48109, USA.
Abstract:
Paclitaxel (Taxol) is an anticancer drug that induces mitotic arrest via microtubule hyperstabilization but causes side effects due to its hydrophobicity and cellular promiscuity. The targeted cytotoxicity of hydrophilic paclitaxel-conjugated polyamidoamine (PAMAM) dendrimers has been demonstrated in cultured cancer cells. Mechanisms of action responsible for this cytotoxicity are unknown, that is, whether the cytotoxicity is due to paclitaxel stabilization of microtubules, as is whether paclitaxel is released intracellularly from the dendrimer. To determine whether the conjugated paclitaxel can bind microtubules, we used a combination of ensemble and single microtubule imaging techniques in vitro. We demonstrate that these conjugates adversely affect microtubules by (1) promoting the polymerization and stabilization of microtubules in a paclitaxel-dependent manner, and (2) bundling preformed microtubules in a paclitaxel-independent manner, potentially due to protonation of tertiary amines in the dendrimer interior. Our results provide mechanistic insights into the cytotoxicity of paclitaxel-conjugated PAMAM dendrimers and uncover unexpected risks of using such conjugates therapeutically.
Insights
Paclitaxel-conjugated dendrimers stabilize microtubules, enhancing anticancer effects. However, they also bundle microtubules independently of paclitaxel, posing potential therapeutic risks.
Area of Science:
- Biochemistry
- Nanotechnology
- Pharmacology
Background:
- Paclitaxel (Taxol) is an effective anticancer drug that stabilizes microtubules, but its hydrophobicity causes side effects.
- Paclitaxel-conjugated polyamidoamine (PAMAM) dendrimers offer targeted delivery and cytotoxicity in cancer cells.
- The precise mechanisms underlying the cytotoxicity of these conjugates remain unclear.
Purpose of the Study:
- To investigate the mechanism of action for paclitaxel-conjugated PAMAM dendrimers.
- To determine if conjugated paclitaxel can bind and affect microtubules.
- To elucidate whether cytotoxicity is due to microtubule stabilization or other factors.
Main Methods:
- In vitro studies utilizing ensemble and single microtubule imaging techniques.
- Analysis of microtubule polymerization and bundling in the presence of paclitaxel-conjugated PAMAM dendrimers.
Main Results:
- Paclitaxel-conjugated dendrimers promote microtubule polymerization and stabilization in a paclitaxel-dependent manner.
- These conjugates also induce microtubule bundling independently of paclitaxel, possibly due to dendrimer protonation.
- The findings suggest dual mechanisms affecting microtubule dynamics.
Conclusions:
- Paclitaxel-conjugated PAMAM dendrimers exert cytotoxicity through paclitaxel-mediated microtubule stabilization.
- An unexpected finding is the paclitaxel-independent microtubule bundling effect of the dendrimer itself.
- These results highlight potential risks associated with using such dendrimer conjugates therapeutically.
Related Concept Videos
Drugs that Stabilize Microtubules
Drugs that Destabilize Microtubules
Destabilization of Microtubules
Microtubule Associated Proteins (MAPs)
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Assembly of Complex Microtubule Structures

